Observatoire des droits humains (anglais seulement)

Experimental Anti-Ebola Serum Used to Treat US Patients

(Version anglaise seulement)

Two Americans who contracted the deadly Ebola disease while working in Africa seem to be improving after being treated with an experimental biotechnology drug that is produced from tobacco. U.S. health authorities have campaigned for years against smoking and using tobacco products to cut down on cancer deaths. But Mapp Biopharmaceutical, a California company with only nine employees, developed the anti-Ebola serum it calls ZMapp from therapeutic proteins found inside tobacco...

Lire l'article complet